Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm

World Journal of Surgery

Volumn 39, Issue 5, 2015, Pages 1268-1273

  Abdel Aziz, Tarek Ezzat ^a,b   Rajeev, Parameswaran ^a   Sadler, Greg ^a   Weaver, Andrew ^c   Mihai, Radu ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; MITOTANE;

ADENOMA; ADJUVANT CHEMOTHERAPY; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; ADULT; AGED; CANCER STAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TUMOR VOLUME; YOUNG ADULT;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL CARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOTANE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TUMOR BURDEN; YOUNG ADULT;

EID: 84939974486     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2912-5     Document Type: Article

References (25)

1. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM (1991) Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110:1014-1021
2. Bovio S, Cataldi A, Reimondo G et al (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298-302
3. Abiven G, Coste J, Groussin L et al (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650-2655
4. Kendrick ML, Lloyd R, Erickson L et al (2001) Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136:543-549
5. Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E (2006) Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? Am Coll Surg 202:423-430
6. Suzuki H (2006) Laparoscopic adrenalectomy for adrenal carcinoma and metastases. Curr Opin Urol 16:47-53
7. Icard P, Goudet P, Charpenay C et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25:891-897. doi: 10.1007/s00268-001-0047-y
8. Weiss LM (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163-169
9. Papotti M, Libè R, Duregon E, Volante M, Bertherat J, Tissier F (2011) The Weiss score and beyond-histopathology for adrenocortical carcinoma. Horm Cancer 2:333-340
10. Efficacy of adjuvant Mitotane treatment in prolonging recurrence-free survival in patients with Adrenocortical Carcinoma at low-intermediate risk of recurrence submitted to radical resection. https://www.epiclin.it/adiuvo Accessed Dec 03 2013
11. Mihai R, Seagroatt V, Goldacre M (2011) Descriptive epidemiological data for adrenocortical carcinoma in the United Kingdom. British Assoc of Endocrine and Thyroid Surgeons meeting, Poitiers
12. Aspinall SR, Imisairi AH, Bliss RD, Scott-Coombes D, Harrison BJ, Lennard TW (2009) How is adrenocortical cancer being managed in the UK? Ann R Coll Surg Engl 91:489-493
13. El-Dhuwaib Y, Lansdown M (2009) Adrenalectomy in England: most are done by surgeons who do less than 5 a year. British Assoc of Endocrine and Thyroid Surgeons meeting, London
14. Hobart MG, Gill IS, Schweizer D, Sung GT, Bravo EL (2000) Laparoscopic adrenalectomy for large-volume (>or = 5 cm) adrenal masses. J Endourol 14:149-154
15. MacGillivray DC, Whalen GF, Malchoff CD, Oppenheim DS, Shichman SJ (2002) Laparoscopic resection of large adrenal tumors. Ann Surg Oncol 9:480-485
16. Walz MK, Petersenn S, Koch JA, Mann K, Neumann HP, Schmid KW (2005) Endoscopic treatment of large primary adrenal tumours. Br J Surg 92:719-723
17. Ramacciato G, Mercantini P, La Torre M et al (2008) Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc 22:516-521
18. Castillo OA, Vitagliano G, Secin FP, Kerkebe M, Arellano L (2008) Laparoscopic adrenalectomy for adrenal masses: does size matter? Urology 71:1138-1141
19. Boylu U, Oommen M, Lee BR, Thomas R (2009) Laparoscopic adrenalectomy for large adrenal masses: pushing the envelope. J Endourol 23:971-975
20. Saunders BD, Doherty GM (2004) Laparoscopic adrenalectomy for malignant disease. Lancet 5:718-726
21. Kebebew E, Siperstein AE, Clark OH, Duh QY (2002) Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 137:948-951
22. Mir MC, Klink JC, Guillotreau J et al (2013) Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: single, high-volume center experience. Ann Surg Oncol 20:1456-1461
23. Jurowich C, Fassnacht M, Kroiss M, Deutschbein T, Germer CT, Reibetanz J (2013) Is there a role for laparoscopic adrenalectomy in patients with suspected adrenocortical carcinoma? A critical appraisal of the literature. Horm Metab Res 45:130-136
24. Mihai R, Iacobone M, Makay O et al (2012) Outcome of operation in patients with adrenocortical cancer invading the inferior vena cava-a European Society of Endocrine Surgeons (ESES) survey. Langenbecks Arch Surg 397:225-231
25. Terzolo M, Angeli A, Fassnacht M et al (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356:2372-2380